Rank | Gene Set | Z-score |
---|---|---|
1 | neutrophil activation involved in immune response (GO:0002283) | 6.24131905 |
2 | modulation by symbiont of host defense response (GO:0052031) | 5.66752619 |
3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.66752619 |
4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.66752619 |
5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.66752619 |
6 | modulation by symbiont of host immune response (GO:0052553) | 5.66752619 |
7 | positive regulation by symbiont of host defense response (GO:0052509) | 5.66752619 |
8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.85571483 |
9 | respiratory burst (GO:0045730) | 4.72103834 |
10 | negative regulation of interleukin-12 production (GO:0032695) | 4.68872506 |
11 | response to peptidoglycan (GO:0032494) | 4.68246209 |
12 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.55299032 |
13 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.50181909 |
14 | granulocyte activation (GO:0036230) | 4.30535881 |
15 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.30379522 |
16 | positive regulation of interferon-alpha production (GO:0032727) | 4.27641578 |
17 | macrophage activation involved in immune response (GO:0002281) | 4.19719989 |
18 | immunoglobulin mediated immune response (GO:0016064) | 4.16775064 |
19 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.09530331 |
20 | regulation of interferon-alpha production (GO:0032647) | 4.07933483 |
21 | neutrophil activation (GO:0042119) | 4.01133714 |
22 | reactive oxygen species biosynthetic process (GO:1903409) | 3.97593783 |
23 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.96751572 |
24 | positive regulation of heat generation (GO:0031652) | 3.85095278 |
25 | glycosphingolipid catabolic process (GO:0046479) | 3.79160283 |
26 | superoxide anion generation (GO:0042554) | 3.77091132 |
27 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.76016197 |
28 | response to host immune response (GO:0052572) | 3.76016197 |
29 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.74737162 |
30 | NIK/NF-kappaB signaling (GO:0038061) | 3.70838628 |
31 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.68150541 |
32 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.66946309 |
33 | regulation of chemokine biosynthetic process (GO:0045073) | 3.65271983 |
34 | regulation of fever generation (GO:0031620) | 3.62736152 |
35 | regulation of mononuclear cell migration (GO:0071675) | 3.60160904 |
36 | myeloid cell activation involved in immune response (GO:0002275) | 3.59631549 |
37 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.55049162 |
38 | positive regulation of mast cell degranulation (GO:0043306) | 3.55049162 |
39 | phagosome maturation (GO:0090382) | 3.47753200 |
40 | regulation of vitamin metabolic process (GO:0030656) | 3.45355863 |
41 | glycolipid catabolic process (GO:0019377) | 3.41154323 |
42 | eosinophil chemotaxis (GO:0048245) | 3.40445033 |
43 | lymphocyte chemotaxis (GO:0048247) | 3.39464552 |
44 | oligosaccharide catabolic process (GO:0009313) | 3.35127789 |
45 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.30154838 |
46 | natural killer cell mediated immunity (GO:0002228) | 3.30154838 |
47 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.30146921 |
48 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.29291641 |
49 | positive regulation of mast cell activation (GO:0033005) | 3.27834694 |
50 | microglial cell activation (GO:0001774) | 3.27353318 |
51 | response to host (GO:0075136) | 3.26512641 |
52 | response to host defenses (GO:0052200) | 3.26512641 |
53 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.26512641 |
54 | positive regulation of leukocyte degranulation (GO:0043302) | 3.25753317 |
55 | T-helper 1 type immune response (GO:0042088) | 3.22985865 |
56 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.22817131 |
57 | response to thyroid hormone (GO:0097066) | 3.20668920 |
58 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.19523128 |
59 | cellular response to type I interferon (GO:0071357) | 3.19040097 |
60 | type I interferon signaling pathway (GO:0060337) | 3.19040097 |
61 | barbed-end actin filament capping (GO:0051016) | 3.18649750 |
62 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.18416583 |
63 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.18140826 |
64 | macrophage activation (GO:0042116) | 3.16067866 |
65 | response to type I interferon (GO:0034340) | 3.13100099 |
66 | leukocyte aggregation (GO:0070486) | 3.12971892 |
67 | amino sugar catabolic process (GO:0046348) | 3.10943114 |
68 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.09770371 |
69 | regulation of heat generation (GO:0031650) | 3.07866387 |
70 | eosinophil migration (GO:0072677) | 3.07508680 |
71 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.06207606 |
72 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.04603469 |
73 | defense response to protozoan (GO:0042832) | 3.03722375 |
74 | regulation of mast cell degranulation (GO:0043304) | 3.01081348 |
75 | regulation of superoxide anion generation (GO:0032928) | 3.00695790 |
76 | regulation of podosome assembly (GO:0071801) | 3.00459153 |
77 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.99426676 |
78 | monocyte chemotaxis (GO:0002548) | 2.99298925 |
79 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.98270695 |
80 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.98209548 |
81 | ceramide catabolic process (GO:0046514) | 2.98086677 |
82 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.96896917 |
83 | response to muramyl dipeptide (GO:0032495) | 2.95736626 |
84 | response to protozoan (GO:0001562) | 2.95007430 |
85 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.94465365 |
86 | protein localization to endosome (GO:0036010) | 2.93003193 |
87 | germinal center formation (GO:0002467) | 2.92593612 |
88 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.92558938 |
89 | negative regulation of interleukin-17 production (GO:0032700) | 2.90799356 |
90 | low-density lipoprotein particle clearance (GO:0034383) | 2.90575690 |
91 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.89671226 |
92 | cyclooxygenase pathway (GO:0019371) | 2.87639402 |
93 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.85910246 |
94 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.83573652 |
95 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.83443815 |
96 | B cell mediated immunity (GO:0019724) | 2.82607351 |
97 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.82242387 |
98 | positive regulation of interferon-beta production (GO:0032728) | 2.81924406 |
99 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.81707650 |
100 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.81465134 |
101 | regulation of early endosome to late endosome transport (GO:2000641) | 2.80584745 |
102 | response to interferon-alpha (GO:0035455) | 2.80426679 |
103 | positive regulation of antigen processing and presentation (GO:0002579) | 2.79789637 |
104 | cellular response to arsenic-containing substance (GO:0071243) | 2.78246676 |
105 | negative regulation of viral genome replication (GO:0045071) | 2.77820821 |
106 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.77358987 |
107 | regulation of leukocyte degranulation (GO:0043300) | 2.77043495 |
108 | leukocyte mediated cytotoxicity (GO:0001909) | 2.77009950 |
109 | myeloid leukocyte activation (GO:0002274) | 2.76693124 |
110 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.76659153 |
111 | leukocyte degranulation (GO:0043299) | 2.76598752 |
112 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.75444003 |
113 | regulation of cholesterol storage (GO:0010885) | 2.74905595 |
114 | positive regulation of lymphocyte migration (GO:2000403) | 2.74866994 |
115 | positive regulation of acute inflammatory response (GO:0002675) | 2.74720449 |
116 | positive regulation of chemokine production (GO:0032722) | 2.73861021 |
117 | cellular response to lipopolysaccharide (GO:0071222) | 2.73546893 |
118 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.73516231 |
119 | regulation of interleukin-17 production (GO:0032660) | 2.73395582 |
120 | regulation of macrophage chemotaxis (GO:0010758) | 2.72904901 |
121 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.72237159 |
122 | response to lipoprotein particle (GO:0055094) | 2.72177865 |
123 | N-acetylneuraminate metabolic process (GO:0006054) | 2.70561024 |
124 | decidualization (GO:0046697) | 2.70053302 |
125 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.69803622 |
126 | membrane lipid catabolic process (GO:0046466) | 2.69225878 |
127 | regulation of mast cell activation (GO:0033003) | 2.69138492 |
128 | myeloid dendritic cell differentiation (GO:0043011) | 2.68850088 |
129 | positive regulation of type 2 immune response (GO:0002830) | 2.68820322 |
130 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.68753575 |
131 | detection of molecule of bacterial origin (GO:0032490) | 2.66911519 |
132 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.66729572 |
133 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.66495270 |
134 | cellular response to molecule of bacterial origin (GO:0071219) | 2.65885144 |
135 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.65215865 |
136 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.65161476 |
137 | regulation of lymphocyte migration (GO:2000401) | 2.64497793 |
138 | neutrophil chemotaxis (GO:0030593) | 2.64041212 |
139 | regulation of antigen processing and presentation (GO:0002577) | 2.62332850 |
140 | pinocytosis (GO:0006907) | 2.61560181 |
141 | negative regulation of cell killing (GO:0031342) | 2.60907402 |
142 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.60907402 |
143 | mature B cell differentiation involved in immune response (GO:0002313) | 2.59436942 |
144 | myeloid dendritic cell activation (GO:0001773) | 2.59000315 |
145 | dendritic cell differentiation (GO:0097028) | 2.58923774 |
146 | virion attachment to host cell (GO:0019062) | 2.58194904 |
147 | adhesion of symbiont to host cell (GO:0044650) | 2.58194904 |
148 | regulation of monocyte chemotaxis (GO:0090025) | 2.57781392 |
149 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.56880155 |
150 | sphingolipid catabolic process (GO:0030149) | 2.55737341 |
151 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.55332086 |
152 | positive regulation of interleukin-6 production (GO:0032755) | 2.55018262 |
153 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.54833944 |
154 | regulation of interleukin-12 production (GO:0032655) | 2.54263985 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.80979331 |
2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.31744557 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.99080812 |
4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.28715170 |
5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.96075742 |
6 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.86980492 |
7 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.56065603 |
8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.51157636 |
9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.25440583 |
10 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.08463735 |
11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.65955544 |
12 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.64166209 |
13 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.36413492 |
14 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.36192378 |
15 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.12747608 |
16 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.11059862 |
17 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.08826199 |
18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.03999077 |
19 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.96572329 |
20 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.90473903 |
21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.88455474 |
22 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.77488920 |
23 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.75652415 |
24 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.71887617 |
25 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.69802308 |
26 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.68482650 |
27 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.67872572 |
28 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.63931410 |
29 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.63845975 |
30 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.60998978 |
31 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.60467577 |
32 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.56170501 |
33 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.54092841 |
34 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.53155729 |
35 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.53155729 |
36 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.52807184 |
37 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.50985293 |
38 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.50293726 |
39 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.49484786 |
40 | SPI1_23127762_ChIP-Seq_K562_Human | 1.49044213 |
41 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.43291686 |
42 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.43182576 |
43 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.41213015 |
44 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.40190394 |
45 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.39406129 |
46 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.38720756 |
47 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.37972276 |
48 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.37012200 |
49 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.35590819 |
50 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.34905345 |
51 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.33244473 |
52 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.31917644 |
53 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.31882743 |
54 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.30931050 |
55 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.30818075 |
56 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.30147517 |
57 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28744119 |
58 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.28310958 |
59 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.25076398 |
60 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23997128 |
61 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23947830 |
62 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23717910 |
63 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.22329060 |
64 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.22256276 |
65 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.22250122 |
66 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.22155188 |
67 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.21890471 |
68 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.21694840 |
69 | MYC_22102868_ChIP-Seq_BL_Human | 1.20045603 |
70 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.19035669 |
71 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.17010205 |
72 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.15239591 |
73 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.14446224 |
74 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.13015441 |
75 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.11816914 |
76 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11535081 |
77 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.11037425 |
78 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.10929047 |
79 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10852908 |
80 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.09241925 |
81 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.09002548 |
82 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.08413306 |
83 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.07942042 |
84 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.07579002 |
85 | * MAF_26560356_Chip-Seq_TH2_Human | 1.07081427 |
86 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.06977488 |
87 | MYB_26560356_Chip-Seq_TH2_Human | 1.05994097 |
88 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.04336899 |
89 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.03803833 |
90 | KDM2B_26808549_Chip-Seq_K562_Human | 1.03252612 |
91 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.02718351 |
92 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.02493891 |
93 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.01269121 |
94 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01125869 |
95 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00021738 |
96 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.99968844 |
97 | GATA3_26560356_Chip-Seq_TH2_Human | 0.97747025 |
98 | * GATA1_19941826_ChIP-Seq_K562_Human | 0.97640471 |
99 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.96900169 |
100 | MAF_26560356_Chip-Seq_TH1_Human | 0.95058806 |
101 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95054996 |
102 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94666254 |
103 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.94644759 |
104 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94568309 |
105 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.92568687 |
106 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.92271055 |
107 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.91841901 |
108 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.91432845 |
109 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91337808 |
110 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.87336574 |
111 | CJUN_26792858_Chip-Seq_BT549_Human | 0.87244794 |
112 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.85494933 |
113 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 0.84148829 |
114 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.83685581 |
115 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.83636796 |
116 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.82296960 |
117 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.81862105 |
118 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.81833470 |
119 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.81240051 |
120 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.79940073 |
121 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.79713802 |
122 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.76875925 |
123 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.74148389 |
124 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.72503226 |
125 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.70857069 |
126 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.70631954 |
127 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.70189092 |
128 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.69296318 |
129 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.68940951 |
130 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.68739711 |
131 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.66977982 |
132 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.66380403 |
133 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.65894321 |
134 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.65838627 |
135 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.65150021 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0006082_CNS_inflammation | 3.86957962 |
2 | MP0001835_abnormal_antigen_presentation | 3.67805971 |
3 | MP0005058_abnormal_lysosome_morphology | 3.55905912 |
4 | MP0003436_decreased_susceptibility_to | 3.55513198 |
5 | MP0009785_altered_susceptibility_to | 3.54456783 |
6 | MP0003303_peritoneal_inflammation | 3.46619705 |
7 | MP0002148_abnormal_hypersensitivity_rea | 3.42223004 |
8 | MP0003724_increased_susceptibility_to | 3.30321783 |
9 | MP0002419_abnormal_innate_immunity | 3.13149999 |
10 | MP0005000_abnormal_immune_tolerance | 3.03919815 |
11 | MP0005025_abnormal_response_to | 2.75914296 |
12 | MP0003806_abnormal_nucleotide_metabolis | 2.72397650 |
13 | MP0004510_myositis | 2.72091477 |
14 | MP0001790_abnormal_immune_system | 2.43491807 |
15 | MP0005387_immune_system_phenotype | 2.43491807 |
16 | MP0000920_abnormal_myelination | 2.36881937 |
17 | MP0001533_abnormal_skeleton_physiology | 2.34545172 |
18 | MP0003075_altered_response_to | 2.33943754 |
19 | MP0003690_abnormal_glial_cell | 2.23848960 |
20 | MP0002452_abnormal_antigen_presenting | 2.21379020 |
21 | MP0002723_abnormal_immune_serum | 2.14910860 |
22 | MP0003172_abnormal_lysosome_physiology | 2.14866931 |
23 | MP0000604_amyloidosis | 2.12018586 |
24 | MP0009840_abnormal_foam_cell | 2.08985694 |
25 | MP0000685_abnormal_immune_system | 2.06340168 |
26 | MP0000343_altered_response_to | 2.05188510 |
27 | MP0005167_abnormal_blood-brain_barrier | 1.99070233 |
28 | MP0003195_calcinosis | 1.98320776 |
29 | MP0009764_decreased_sensitivity_to | 1.96408662 |
30 | MP0005671_abnormal_response_to | 1.93144060 |
31 | MP0002139_abnormal_hepatobiliary_system | 1.89699488 |
32 | MP0005464_abnormal_platelet_physiology | 1.87148699 |
33 | MP0002877_abnormal_melanocyte_morpholog | 1.86756714 |
34 | MP0001800_abnormal_humoral_immune | 1.86739886 |
35 | MP0003448_altered_tumor_morphology | 1.82034695 |
36 | MP0004947_skin_inflammation | 1.80149086 |
37 | MP0001819_abnormal_immune_cell | 1.79894227 |
38 | MP0002998_abnormal_bone_remodeling | 1.76364501 |
39 | MP0002420_abnormal_adaptive_immunity | 1.76237551 |
40 | MP0008004_abnormal_stomach_pH | 1.73167938 |
41 | MP0003191_abnormal_cellular_cholesterol | 1.68064427 |
42 | * MP0001845_abnormal_inflammatory_respons | 1.63794511 |
43 | MP0005164_abnormal_response_to | 1.58191817 |
44 | MP0005166_decreased_susceptibility_to | 1.56964369 |
45 | MP0004858_abnormal_nervous_system | 1.56003009 |
46 | * MP0008469_abnormal_protein_level | 1.54288690 |
47 | MP0002405_respiratory_system_inflammati | 1.53315211 |
48 | MP0005310_abnormal_salivary_gland | 1.50409102 |
49 | MP0001853_heart_inflammation | 1.48515475 |
50 | MP0006054_spinal_hemorrhage | 1.43817832 |
51 | * MP0003186_abnormal_redox_activity | 1.37495310 |
52 | MP0003950_abnormal_plasma_membrane | 1.36799704 |
53 | MP0009278_abnormal_bone_marrow | 1.36574027 |
54 | MP0008260_abnormal_autophagy | 1.33209204 |
55 | MP0003329_amyloid_beta_deposits | 1.32255864 |
56 | MP0003656_abnormal_erythrocyte_physiolo | 1.31461400 |
57 | MP0010155_abnormal_intestine_physiology | 1.24048474 |
58 | MP0000858_altered_metastatic_potential | 1.23269117 |
59 | MP0001851_eye_inflammation | 1.20736173 |
60 | MP0003300_gastrointestinal_ulcer | 1.18232888 |
61 | MP0002006_tumorigenesis | 1.15201559 |
62 | MP0009333_abnormal_splenocyte_physiolog | 1.13604554 |
63 | MP0000716_abnormal_immune_system | 1.11904791 |
64 | MP0008438_abnormal_cutaneous_collagen | 1.11770833 |
65 | MP0002933_joint_inflammation | 1.09402926 |
66 | MP0003634_abnormal_glial_cell | 1.08078166 |
67 | MP0005390_skeleton_phenotype | 1.03729204 |
68 | MP0001958_emphysema | 1.00783404 |
69 | MP0004782_abnormal_surfactant_physiolog | 0.96773165 |
70 | MP0002277_abnormal_respiratory_mucosa | 0.95111820 |
71 | MP0009765_abnormal_xenobiotic_induced | 0.93423785 |
72 | MP0002254_reproductive_system_inflammat | 0.93238459 |
73 | MP0005451_abnormal_body_composition | 0.91206648 |
74 | MP0005083_abnormal_biliary_tract | 0.90563927 |
75 | MP0005171_absent_coat_pigmentation | 0.90099235 |
76 | MP0002332_abnormal_exercise_endurance | 0.88746490 |
77 | MP0001501_abnormal_sleep_pattern | 0.88235013 |
78 | MP0008874_decreased_physiological_sensi | 0.87270975 |
79 | MP0003453_abnormal_keratinocyte_physiol | 0.87241506 |
80 | MP0003279_aneurysm | 0.87228902 |
81 | MP0000465_gastrointestinal_hemorrhage | 0.86120251 |
82 | MP0005397_hematopoietic_system_phenotyp | 0.85241667 |
83 | MP0001545_abnormal_hematopoietic_system | 0.85241667 |
84 | MP0002398_abnormal_bone_marrow | 0.83680841 |
85 | MP0000371_diluted_coat_color | 0.82888842 |
86 | MP0002429_abnormal_blood_cell | 0.82644357 |
87 | MP0003828_pulmonary_edema | 0.80866863 |
88 | MP0004883_abnormal_blood_vessel | 0.80608320 |
89 | MP0003705_abnormal_hypodermis_morpholog | 0.80178913 |
90 | MP0001849_ear_inflammation | 0.79773991 |
91 | MP0002090_abnormal_vision | 0.79346499 |
92 | * MP0009763_increased_sensitivity_to | 0.79198817 |
93 | MP0003633_abnormal_nervous_system | 0.78724933 |
94 | MP0000249_abnormal_blood_vessel | 0.78333635 |
95 | MP0005165_increased_susceptibility_to | 0.75160188 |
96 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.75109176 |
97 | MP0002295_abnormal_pulmonary_circulatio | 0.73013344 |
98 | MP0005257_abnormal_intraocular_pressure | 0.70773969 |
99 | MP0004233_abnormal_muscle_weight | 0.68454447 |
100 | * MP0000689_abnormal_spleen_morphology | 0.68386037 |
101 | MP0003795_abnormal_bone_structure | 0.67919860 |
102 | MP0005535_abnormal_body_temperature | 0.66565291 |
103 | MP0005076_abnormal_cell_differentiation | 0.66399589 |
104 | MP0002136_abnormal_kidney_physiology | 0.66116516 |
105 | MP0005595_abnormal_vascular_smooth | 0.64665742 |
106 | MP0008873_increased_physiological_sensi | 0.64067164 |
107 | MP0003183_abnormal_peptide_metabolism | 0.62202505 |
108 | MP0003091_abnormal_cell_migration | 0.61310899 |
109 | MP0002722_abnormal_immune_system | 0.60948764 |
110 | MP0001542_abnormal_bone_strength | 0.60430843 |
111 | MP0010307_abnormal_tumor_latency | 0.57900974 |
112 | MP0003566_abnormal_cell_adhesion | 0.57730850 |
113 | MP0000015_abnormal_ear_pigmentation | 0.57251697 |
114 | MP0003631_nervous_system_phenotype | 0.56402624 |
115 | MP0010386_abnormal_urinary_bladder | 0.56366925 |
116 | MP0001663_abnormal_digestive_system | 0.53913621 |
117 | MP0005647_abnormal_sex_gland | 0.52211229 |
118 | MP0003136_yellow_coat_color | 0.50900276 |
119 | MP0005023_abnormal_wound_healing | 0.50018306 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 6.91835545 |
2 | Eczematoid dermatitis (HP:0000976) | 6.91495730 |
3 | Recurrent bacterial skin infections (HP:0005406) | 6.39161536 |
4 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.97450475 |
5 | Abnormality of macrophages (HP:0004311) | 5.73656446 |
6 | Axonal loss (HP:0003447) | 5.26956799 |
7 | Increased cerebral lipofuscin (HP:0011813) | 5.07931833 |
8 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.73886390 |
9 | Vacuolated lymphocytes (HP:0001922) | 4.53493715 |
10 | Mediastinal lymphadenopathy (HP:0100721) | 4.53300835 |
11 | Stomatitis (HP:0010280) | 4.41462627 |
12 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 4.23722273 |
13 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.02417024 |
14 | Recurrent skin infections (HP:0001581) | 3.96940483 |
15 | Systemic lupus erythematosus (HP:0002725) | 3.92657293 |
16 | Autoimmune thrombocytopenia (HP:0001973) | 3.87656150 |
17 | Obstructive lung disease (HP:0006536) | 3.76511315 |
18 | Chronic obstructive pulmonary disease (HP:0006510) | 3.76511315 |
19 | Gingivitis (HP:0000230) | 3.76189328 |
20 | Neurofibrillary tangles (HP:0002185) | 3.73906289 |
21 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.69962315 |
22 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.69962315 |
23 | Abnormality of glycolipid metabolism (HP:0010969) | 3.69962315 |
24 | Dysostosis multiplex (HP:0000943) | 3.46587674 |
25 | Nuclear cataract (HP:0100018) | 3.35471456 |
26 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.32415639 |
27 | Disinhibition (HP:0000734) | 3.26612047 |
28 | Interstitial pulmonary disease (HP:0006530) | 3.23599984 |
29 | Hepatosplenomegaly (HP:0001433) | 3.19922070 |
30 | Orchitis (HP:0100796) | 3.17051608 |
31 | Supranuclear gaze palsy (HP:0000605) | 3.08530079 |
32 | Loss of speech (HP:0002371) | 3.04418013 |
33 | Myositis (HP:0100614) | 3.04038970 |
34 | Urticaria (HP:0001025) | 3.03710864 |
35 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.96465230 |
36 | Cellulitis (HP:0100658) | 2.95709357 |
37 | Vasculitis (HP:0002633) | 2.92093155 |
38 | Tetraparesis (HP:0002273) | 2.90062688 |
39 | Recurrent fungal infections (HP:0002841) | 2.89386172 |
40 | Parakeratosis (HP:0001036) | 2.83350772 |
41 | Basal ganglia calcification (HP:0002135) | 2.83230141 |
42 | Optic neuritis (HP:0100653) | 2.79864690 |
43 | Retrobulbar optic neuritis (HP:0100654) | 2.79864690 |
44 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.69797365 |
45 | Mucopolysacchariduria (HP:0008155) | 2.69797365 |
46 | Cerebral inclusion bodies (HP:0100314) | 2.64243738 |
47 | Thick nail (HP:0001805) | 2.59260200 |
48 | Poor head control (HP:0002421) | 2.54953914 |
49 | Glomerulonephritis (HP:0000099) | 2.54820705 |
50 | Prostate neoplasm (HP:0100787) | 2.54618399 |
51 | Increased IgM level (HP:0003496) | 2.52710024 |
52 | Upper motor neuron abnormality (HP:0002127) | 2.49761575 |
53 | Recurrent pneumonia (HP:0006532) | 2.49071185 |
54 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.46535404 |
55 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.46535404 |
56 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.46535404 |
57 | Peripheral demyelination (HP:0011096) | 2.42590035 |
58 | Vertebral compression fractures (HP:0002953) | 2.36990336 |
59 | * Increased serum ferritin (HP:0003281) | 2.35304853 |
60 | Recurrent viral infections (HP:0004429) | 2.31437248 |
61 | Amyloidosis (HP:0011034) | 2.31225951 |
62 | Chronic otitis media (HP:0000389) | 2.29950959 |
63 | Pustule (HP:0200039) | 2.26973844 |
64 | Myocardial infarction (HP:0001658) | 2.24897161 |
65 | Osteolytic defects of the hand bones (HP:0009699) | 2.23317229 |
66 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.23317229 |
67 | Osteomyelitis (HP:0002754) | 2.20466124 |
68 | Pathologic fracture (HP:0002756) | 2.19877445 |
69 | Bone pain (HP:0002653) | 2.17472994 |
70 | Recurrent lower respiratory tract infections (HP:0002783) | 2.16798072 |
71 | Dementia (HP:0000726) | 2.15357268 |
72 | Hypergammaglobulinemia (HP:0010702) | 2.15088367 |
73 | Petechiae (HP:0000967) | 2.14320870 |
74 | Complement deficiency (HP:0004431) | 2.14150482 |
75 | Prolonged neonatal jaundice (HP:0006579) | 2.14006660 |
76 | Purpura (HP:0000979) | 2.12727614 |
77 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.12420671 |
78 | Personality changes (HP:0000751) | 2.11260991 |
79 | Slow saccadic eye movements (HP:0000514) | 2.10563967 |
80 | Spastic tetraparesis (HP:0001285) | 2.07392824 |
81 | Esophageal neoplasm (HP:0100751) | 2.06660517 |
82 | Neoplasm of head and neck (HP:0012288) | 2.06660517 |
83 | Metaphyseal irregularity (HP:0003025) | 2.06474843 |
84 | Recurrent cutaneous fungal infections (HP:0011370) | 2.04510853 |
85 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.04510853 |
86 | Apathy (HP:0000741) | 2.03198957 |
87 | Abnormality of complement system (HP:0005339) | 2.02374358 |
88 | Periodontitis (HP:0000704) | 2.01407087 |
89 | Hypertensive crisis (HP:0100735) | 2.01195515 |
90 | Peritonitis (HP:0002586) | 2.00318909 |
91 | Diminished motivation (HP:0000745) | 1.99380822 |
92 | Pulmonary infiltrates (HP:0002113) | 1.97173297 |
93 | Progressive visual loss (HP:0000529) | 1.95148950 |
94 | Asymmetric septal hypertrophy (HP:0001670) | 1.94531528 |
95 | Premature loss of primary teeth (HP:0006323) | 1.93818780 |
96 | J-shaped sella turcica (HP:0002680) | 1.93457557 |
97 | Meningitis (HP:0001287) | 1.93142476 |
98 | Spontaneous hematomas (HP:0007420) | 1.92433609 |
99 | Clumsiness (HP:0002312) | 1.90043022 |
100 | Nephritis (HP:0000123) | 1.89558167 |
101 | Mutism (HP:0002300) | 1.88617892 |
102 | Cholecystitis (HP:0001082) | 1.88198457 |
103 | Abnormal gallbladder physiology (HP:0012438) | 1.88198457 |
104 | Leukocytosis (HP:0001974) | 1.87542106 |
105 | Cerebral hemorrhage (HP:0001342) | 1.87270557 |
106 | Epistaxis (HP:0000421) | 1.86515654 |
107 | Hematochezia (HP:0002573) | 1.85483687 |
108 | Prolonged bleeding time (HP:0003010) | 1.84744817 |
109 | Gingival bleeding (HP:0000225) | 1.83960443 |
110 | Juvenile onset (HP:0003621) | 1.83451452 |
111 | Inappropriate behavior (HP:0000719) | 1.83237575 |
112 | Neuronal loss in central nervous system (HP:0002529) | 1.81826337 |
113 | Hemoptysis (HP:0002105) | 1.81516073 |
114 | Nausea (HP:0002018) | 1.80957220 |
115 | * Abnormality of iron homeostasis (HP:0011031) | 1.80781596 |
116 | Abnormality of the nasal mucosa (HP:0000433) | 1.80471451 |
117 | Onion bulb formation (HP:0003383) | 1.80291711 |
118 | Agnosia (HP:0010524) | 1.79014901 |
119 | Progressive neurologic deterioration (HP:0002344) | 1.78837604 |
120 | Polycythemia (HP:0001901) | 1.78420161 |
121 | Achilles tendon contracture (HP:0001771) | 1.75627473 |
122 | Malnutrition (HP:0004395) | 1.74755471 |
123 | Conjunctival telangiectasia (HP:0000524) | 1.73246726 |
124 | Cervical subluxation (HP:0003308) | 1.73221991 |
125 | Gastrointestinal infarctions (HP:0005244) | 1.73114319 |
126 | Hyperparathyroidism (HP:0000843) | 1.72946811 |
127 | Cardiomegaly (HP:0001640) | 1.72617468 |
128 | Thin bony cortex (HP:0002753) | 1.71423202 |
129 | Keratoconjunctivitis sicca (HP:0001097) | 1.71365146 |
130 | Thoracic kyphosis (HP:0002942) | 1.71312350 |
131 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.71296549 |
132 | Polyneuropathy (HP:0001271) | 1.71126834 |
133 | Spondylolisthesis (HP:0003302) | 1.70183104 |
134 | Retinal atrophy (HP:0001105) | 1.67490330 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PBK | 5.95867876 |
2 | RIPK4 | 4.57546064 |
3 | MAP3K14 | 3.40444778 |
4 | TBK1 | 3.24897653 |
5 | BLK | 3.17407155 |
6 | TAOK2 | 2.58847664 |
7 | EPHB1 | 2.58576058 |
8 | IKBKE | 2.51811566 |
9 | DDR2 | 2.46311068 |
10 | ERN1 | 2.24770791 |
11 | IRAK4 | 2.14627702 |
12 | IRAK3 | 2.10895065 |
13 | MAP3K3 | 2.05846479 |
14 | TYK2 | 2.02789008 |
15 | PRPF4B | 1.90156042 |
16 | BMX | 1.85126587 |
17 | ARAF | 1.84964651 |
18 | MAP3K13 | 1.84844845 |
19 | IKBKB | 1.82023551 |
20 | TAOK1 | 1.80169219 |
21 | PIM2 | 1.79243876 |
22 | KIT | 1.68948624 |
23 | FGR | 1.62954903 |
24 | MAP4K1 | 1.60186086 |
25 | ABL2 | 1.58472740 |
26 | MAP2K3 | 1.57630621 |
27 | MST4 | 1.53256967 |
28 | SIK3 | 1.43501857 |
29 | KSR2 | 1.38439998 |
30 | JAK1 | 1.36322212 |
31 | JAK3 | 1.36058382 |
32 | NME2 | 1.34342306 |
33 | MST1R | 1.34254026 |
34 | TXK | 1.33750228 |
35 | STK39 | 1.33571683 |
36 | CSK | 1.28457360 |
37 | MAPKAPK5 | 1.28208673 |
38 | CDC42BPA | 1.27869011 |
39 | BMPR2 | 1.15292944 |
40 | SIK1 | 1.08737848 |
41 | MET | 1.07907219 |
42 | HCK | 1.07429598 |
43 | TESK2 | 1.06744849 |
44 | SYK | 1.05851142 |
45 | PAK4 | 1.03039833 |
46 | TESK1 | 0.97101403 |
47 | LIMK1 | 0.95927213 |
48 | LYN | 0.94352474 |
49 | CLK1 | 0.94322842 |
50 | SCYL2 | 0.93322317 |
51 | MAP3K1 | 0.91943175 |
52 | MATK | 0.91447033 |
53 | MOS | 0.91056423 |
54 | PKN1 | 0.87963868 |
55 | OXSR1 | 0.87961881 |
56 | ZAP70 | 0.86278021 |
57 | JAK2 | 0.85527389 |
58 | MAP3K11 | 0.84003097 |
59 | LCK | 0.83714763 |
60 | MARK3 | 0.83385939 |
61 | CHUK | 0.83279364 |
62 | CSF1R | 0.79390252 |
63 | LATS2 | 0.78592500 |
64 | DAPK3 | 0.78588149 |
65 | GRK7 | 0.77862459 |
66 | NTRK1 | 0.73805692 |
67 | LRRK2 | 0.72578096 |
68 | PRKCD | 0.71696696 |
69 | PDPK1 | 0.71396499 |
70 | PDGFRA | 0.70411399 |
71 | ABL1 | 0.70204197 |
72 | PDK2 | 0.66889675 |
73 | STK4 | 0.66855897 |
74 | RIPK1 | 0.66552652 |
75 | NEK9 | 0.64693888 |
76 | TRPM7 | 0.64659330 |
77 | FES | 0.64627572 |
78 | EGFR | 0.64602068 |
79 | RPS6KA4 | 0.63392424 |
80 | ADRBK2 | 0.62282923 |
81 | LMTK2 | 0.60715851 |
82 | GRK6 | 0.60666730 |
83 | IRAK2 | 0.60261236 |
84 | ICK | 0.58889509 |
85 | TRIB3 | 0.58026680 |
86 | MAP3K2 | 0.55744222 |
87 | BCKDK | 0.55447876 |
88 | IRAK1 | 0.55222969 |
89 | BTK | 0.54932716 |
90 | EPHA3 | 0.54207776 |
91 | MAP2K2 | 0.52314491 |
92 | PIM1 | 0.51362475 |
93 | FYN | 0.51098439 |
94 | TTN | 0.51023286 |
95 | PRKCQ | 0.50928163 |
96 | PRKD2 | 0.50043068 |
97 | STK10 | 0.48723767 |
98 | PRKG2 | 0.48081118 |
99 | CAMKK2 | 0.48077531 |
100 | ERBB4 | 0.47434495 |
101 | MAPKAPK2 | 0.46246999 |
102 | PDK1 | 0.46107756 |
103 | BCR | 0.45309207 |
104 | EPHA2 | 0.44606623 |
105 | MAPKAPK3 | 0.43928913 |
106 | EPHB2 | 0.43256057 |
107 | SIK2 | 0.40719422 |
108 | WNK4 | 0.40243401 |
109 | TGFBR2 | 0.39310213 |
110 | MAPK4 | 0.39302940 |
111 | FGFR4 | 0.37729059 |
112 | DYRK3 | 0.37568498 |
113 | TYRO3 | 0.37353728 |
114 | BMPR1B | 0.37329328 |
115 | MAP3K9 | 0.37187271 |
116 | RPS6KL1 | 0.37140522 |
117 | RPS6KC1 | 0.37140522 |
118 | MAP3K5 | 0.36494084 |
119 | WNK1 | 0.36418601 |
120 | ACVR1B | 0.35576754 |
121 | PRKCE | 0.35054359 |
122 | PRKD1 | 0.34692463 |
123 | MAP3K8 | 0.34546015 |
124 | RPS6KA5 | 0.34287530 |
125 | KDR | 0.34270780 |
126 | BRAF | 0.33603437 |
127 | RPS6KA2 | 0.33353709 |
128 | PRKCH | 0.33282259 |
129 | TAOK3 | 0.32730449 |
130 | PTK2B | 0.31988915 |
131 | MARK2 | 0.31205183 |
132 | DAPK2 | 0.30993561 |
133 | PAK6 | 0.30657950 |
134 | PAK1 | 0.28614552 |
135 | SRC | 0.28181180 |
136 | GSK3A | 0.28001248 |
137 | CAMK2D | 0.27801609 |
138 | CAMK2G | 0.24206695 |
139 | PLK2 | 0.23489531 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.30588732 |
2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.18596059 |
3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.90060952 |
4 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.83154792 |
5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.75149561 |
6 | Lysosome_Homo sapiens_hsa04142 | 2.57971840 |
7 | Malaria_Homo sapiens_hsa05144 | 2.47078048 |
8 | Pertussis_Homo sapiens_hsa05133 | 2.45775013 |
9 | Legionellosis_Homo sapiens_hsa05134 | 2.32706006 |
10 | Tuberculosis_Homo sapiens_hsa05152 | 2.31387854 |
11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.23493323 |
12 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.22374312 |
13 | Phagosome_Homo sapiens_hsa04145 | 2.19692450 |
14 | Salmonella infection_Homo sapiens_hsa05132 | 2.19295848 |
15 | Asthma_Homo sapiens_hsa05310 | 2.13135280 |
16 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.09142935 |
17 | Allograft rejection_Homo sapiens_hsa05330 | 1.99038648 |
18 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.93796344 |
19 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.79004637 |
20 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.78740458 |
21 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.76064772 |
22 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.72657311 |
23 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.71346905 |
24 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.70503880 |
25 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.68461866 |
26 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.47113519 |
27 | Measles_Homo sapiens_hsa05162 | 1.46554268 |
28 | Influenza A_Homo sapiens_hsa05164 | 1.43275795 |
29 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.43163612 |
30 | Bladder cancer_Homo sapiens_hsa05219 | 1.37742688 |
31 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.37202234 |
32 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.36840566 |
33 | Shigellosis_Homo sapiens_hsa05131 | 1.34086358 |
34 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.26906185 |
35 | Prion diseases_Homo sapiens_hsa05020 | 1.25364886 |
36 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.23887336 |
37 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.23329552 |
38 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.22597493 |
39 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.19982288 |
40 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.13718488 |
41 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.12366074 |
42 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.10926900 |
43 | Other glycan degradation_Homo sapiens_hsa00511 | 1.05169163 |
44 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.04781242 |
45 | Apoptosis_Homo sapiens_hsa04210 | 1.03969054 |
46 | Amoebiasis_Homo sapiens_hsa05146 | 1.02333899 |
47 | Galactose metabolism_Homo sapiens_hsa00052 | 1.01585014 |
48 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.00760755 |
49 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.97230612 |
50 | Hepatitis C_Homo sapiens_hsa05160 | 0.87822619 |
51 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.86706880 |
52 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.86190856 |
53 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.85825437 |
54 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.83284001 |
55 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.82258953 |
56 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.81606372 |
57 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.81186021 |
58 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.80199715 |
59 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.79555428 |
60 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.79005294 |
61 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.78021506 |
62 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.74723968 |
63 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.74470974 |
64 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.74244393 |
65 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.73358724 |
66 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.71809367 |
67 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.66766431 |
68 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.66526149 |
69 | * Mineral absorption_Homo sapiens_hsa04978 | 0.65536686 |
70 | Hepatitis B_Homo sapiens_hsa05161 | 0.64898109 |
71 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.58265071 |
72 | Endocytosis_Homo sapiens_hsa04144 | 0.58166051 |
73 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.57737143 |
74 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.57721509 |
75 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.55617437 |
76 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.55307465 |
77 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.51615594 |
78 | Histidine metabolism_Homo sapiens_hsa00340 | 0.50825325 |
79 | Viral myocarditis_Homo sapiens_hsa05416 | 0.50813695 |
80 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.48261661 |
81 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.47764241 |
82 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.46904313 |
83 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.46233773 |
84 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.44630107 |
85 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.44025160 |
86 | Platelet activation_Homo sapiens_hsa04611 | 0.43732013 |
87 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.40517161 |
88 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.37334167 |
89 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.35640754 |
90 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.35427147 |
91 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.35182442 |
92 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.34438988 |
93 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.33143384 |
94 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.30363832 |
95 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.29255637 |
96 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.28691374 |
97 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.28491700 |
98 | HTLV-I infection_Homo sapiens_hsa05166 | 0.28353839 |
99 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.27040218 |
100 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.25802434 |
101 | Alzheimers disease_Homo sapiens_hsa05010 | 0.25613262 |
102 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.24195282 |
103 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.22517083 |
104 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.22403618 |
105 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.19632435 |
106 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.18222123 |
107 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.18186766 |
108 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.17114089 |
109 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.16962709 |
110 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.16752011 |
111 | Insulin resistance_Homo sapiens_hsa04931 | 0.15545075 |
112 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.15203315 |
113 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.14815146 |
114 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.13973180 |
115 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.13602387 |
116 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.12106246 |
117 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.10327840 |